Literature DB >> 11495717

Olanzapine for the treatment of fibromyalgia symptoms.

R S Kiser1, H M Cohen, R N Freedenfeld, C Jewell, P N Fuchs.   

Abstract

Fibromyalgia is a chronic condition that is diagnosed primarily by the presence of generalized pain along with tenderness on palpation of certain body regions. Unfortunately, the pharmacological treatment of fibromyalgia remains problematic. Two patients are described who highlight the use of the atypical neuroleptic olanzapine for the control of symptoms related to fibromyalgia. Prior to the use of olanzapine, both patients had received a multitude of treatments, none of which greatly improved their ability to function in daily activities. With olanzapine, both patients reported a significant decrease in pain and marked improvement in daily functioning. In one case, the pain returned during a period of time when olanzapine was discontinued, an effect that was reversed when olanzapine was reintroduced. The paucity of serious side effects (i.e., extrapyramidal signs) with the atypical neuroleptic olanzapine strongly favors further exploration and use of this drug for the treatment of fibromyalgia symptoms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11495717     DOI: 10.1016/s0885-3924(01)00302-5

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

Review 1.  Neuropharmacologic targets and agents in fibromyalgia.

Authors:  Rie Suzuki; Anthony H Dickenson
Journal:  Curr Pain Headache Rep       Date:  2002-08

2.  [Pharmacological treatment of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Berliner; W Brückle; S Ehlers; K Mönkemöller; B Moradi; F Petzke; N Uçeyler; R Wörz; E Winter; D O Nutzinger
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 3.  The role of antipsychotics in the management of fibromyalgia.

Authors:  Elena P Calandre; Fernando Rico-Villademoros
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

4.  Use of ziprasidone in patients with fibromyalgia: a case series.

Authors:  Elena P Calandre; Javier Hidalgo; Fernando Rico-Villademoros
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

Review 5.  Management of fibromyalgia.

Authors:  Ashwin A Patkar; Louai Bilal; Prakash S Masand
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

6.  Olanzapine Attenuates Mechanical Allodynia in a Rat Model of Partial Sciatic Nerve Ligation.

Authors:  Taeko Fukuda; Soichiro Yamashita; Setsuji Hisano; Makoto Tanaka
Journal:  Korean J Pain       Date:  2015-07-01

Review 7.  Advances in diagnostic and treatment options in patients with fibromyalgia syndrome.

Authors:  Ali Gur; Pelin Oktayoglu
Journal:  Open Access Rheumatol       Date:  2009-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.